The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index; none of the 27 sources its claims cite is checked for support yet.
Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology
Open accessOverview
CoChat Summary
TL;DR
a-Factor from S. cerevisiae and two benzophenone-containing photoactive analogues were synthesized by Fmoc solid-phase peptide synthesis using hydrazinobenzoyl AM NovaGel resin. The synthetic a-factor was structurally confirmed and was equipotent to prior synthetic a-factor in a yeast growth arrest assay, while the analogues retained 25–50% of parent activity.
Key findings
- Synthetic a-factor (1) was prepared via a fully protected peptide oxidative-cleavage route; its structure was confirmed by ESI-MS-MS and 2D 1H-1H TOCSY NMR, with NMR matching prior a-factor data.
- In the yeast growth arrest assay, synthetic a-factor gave an endpoint of 0.12 ng, identical to a previously characterized synthetic a-factor; analogues 2 and 3 gave endpoints of 0.25 ng and 0.50 ng, respectively, corresponding to 25–50% of parent activity.
- Yields reported include peptide 9 at 21.4 mg (14% from 110 μmol peptide resin, 90% HPLC purity); a-factor second synthesis at 19% by mass versus 65% by DTNB/UV; analogue 2 at 8% by mass (90% purity); and analogue 3 at 14% by mass (97% purity).
Methods
- Fmoc SPPS on 4-Fmoc-hydrazinobenzoyl AM NovaGel resin, N-terminal Boc protection, Cu(II)/O2 oxidative cleavage to give the C-terminal methyl ester, Reagent K side-chain deprotection, and Zn(OAc)2-catalyzed alkylation of the cysteine thiol with farnesyl bromide or benzophenone bromides Br-BC5/Br-BC10.
- Characterization by RP-HPLC, ESI-MS-MS on a QSTAR instrument selecting the doubly charged [M+2H]2+ species, and 2D 1H-1H TOCSY NMR for a-factor.
- Biological activity by yeast growth arrest assay using S. cerevisiae RC757 (MATα) and LM102 (MATa) controls; peptides were spotted in triplicate, and the endpoint was the lowest concentration producing a clear zone of inhibition.
Limitations
- The paper states that initial on-resin oxidative cleavage of an unprotected peptide gave a complex mixture with only trace desired product, possibly due to unprotected tryptophan instability or side-chain copper chelation/interference; successful cleavage required a fully protected peptide.
- The paper notes that apparent mass-based yields (8–19%) likely reflect H2O and/or TFA salts and uncertainty in small (~1–2 mg) masses; DTNB/UV analysis gave 65% for a-factor.
- Evident from the text: biological evaluation is limited to growth arrest, with no photoaffinity labeling or receptor-binding data reported, and analogues 2 and 3 were confirmed by MS-MS only, not NMR.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 11 Not checked · 3 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the structures of the analogues were confirmed by MS-MS analysis”
- Also stated in: § 2.3. Mass spectrometric analysis of a-factor and two related photoactive analogues · boosted
“In aggregate, these data clearly confirm the successful preparation of a-factor and related analogues.”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > Abstract
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.3. Mass spectrometric analysis of a-factor and two related photoactive analogues · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the structure of the synthetic a-factor was confirmed by MS-MS analysis and NMR”
- Also stated in: § 2.5. 1H NMR analysis of a-factor (1) produced and photoactive analogues · boosted
“Comparison of this spectral data with data previously reported for a-factor (prepared via a different route employing Boc/Bzl protection) shows excellent agreement.”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > Abstract
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.5. 1H NMR analysis of a-factor (1) produced and photoactive analogues · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using a yeast growth arrest assay, the analogues were found to have activity comparable to a-factor itself.”
- Also stated in: § 2.6. Biological assay of synthetic a-factor and photoactive analogues · plain
“the photoactive analogues retain most (25–50%) of the biological activity of the parent a-factor pheromone.”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 2.6. Biological assay of synthetic a-factor and photoactive analogues · plain
In the paper
“The binding of a-factor to its receptor is one example of this latter phenomenon.7”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > 1. Introduction
What the sources say
- Not matchedcites [7] Dawe AL Becker JM Jiang Y Naider F Eummer JT Mu YQ Gibbs RA Biochemistry 1997 36 12036 9315841
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
In the paper
“One of these peptides is a-factor (1), a dodecapeptide that incorporates farnesylcysteine methyl ester as its C-terminal residue.2”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > 1. Introduction
What the sources say
- Not matchedcites [2] Anderegg RJ Betz R Carr SA Crabb JW Duntze W J Biol Chem 1988 263 18236 3056940
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
- It may state two separate claims as one. 5
- Probably not a substantial claim. 6
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Our group has develop more streamlined methods for the synthesis of a-factor, first using hydrazine-containing resin followed by oxidative resin cleavage (Mullen et al., 2011), and then more recently by side-chain anchoring to trityl chloride resin (Diaz-Rodriguez, Ganusova, Rappe, Becker, & Distefano, 2015; Diaz-Rodriguez, Mullen, Ganusova, Becker, & Distefano, 2012).”
From Synthesis and NMR Characterization of the Prenylated Peptide, a-Factor (2019) · cites this paper as Mullen et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > 2. Results and Discussion > 2.2. Successful approach of a-factor and analogues via a fully protected peptide
“Oxidative cleavage by Cu(I) with methanol as a cosolvent furnished fully protected methyl ester 8”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > 4. Experimental > 4.2. Chemical Synthesis
“To the resin was then added Cu(II)acetate (110 μmol, 20 mg)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > 4. Experimental > 4.2. Chemical Synthesis
“YIIKGVFWDPAC-OCH3 (9, 10 mg, 7.0 μmmol)”
§ Synthesis of a-factor peptide from Saccharomyces cerevisiae and photoactive analogues via Fmoc solid phase methodology > 4. Experimental > 4.2. Chemical Synthesis
“YIIKGVFWDPAC-OCH3 (9, 10 mg, 7.0 μmol)”
Citations
Cites
Stewart, J. M. (1976) · Journal of Macromolecular Science: Part A - Chemistry · doi:10.1080/00222337608068099 · Cited by 1,767
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 1,743
Ellman's reagent: 5,5′-dithiobis(2-nitrobenzoic acid)—a reexamination
Riddles, P. W., Blakeley, R. L., & Zerner, B. (1979) · Analytical Biochemistry · doi:10.1016/0003-2697(79)90792-9 · Cited by 1,015
Handbook of Biochemistry and Molecular Biology
(2010) · CRC Press eBooks · doi:10.1201/b10501 · Cited by 803
Solid phase peptide synthesis; a practical approach
(1991) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(91)90598-7 · Cited by 762
A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis
KING, D. S., FIELDS, C. G., & FIELDS, G. B. (1990) · International Journal of Peptide and Protein Research · doi:10.1111/j.1399-3011.1990.tb00976.x · Cited by 725
Anderegg, R. J., Betz, R., Carr, S. A., Crabb, J. W., & Duntze, W. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81351-0 · Cited by 370
(2020) · Catalysis from A to Z · doi:10.1002/9783527809080.cataz15424 · Cited by 234
Kurjan, J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.005313 · Cited by 200
Therapeutic intervention based on protein prenylation and associated modifications
Gelb, M. H., Brunsveld, L., Hrycyna, C. A., Michaelis, S., Tamanoi, F., Van Voorhis, W. C., & Waldmann, H. (2006) · Nature Chemical Biology · doi:10.1038/nchembio818 · Cited by 194
Research works printed but not linked: 2
- Marcus, 1991, Mol. Cell. Biol., 11, 3603
- Ludolph, 2002, J. Am. Chem. Soc., 124, 5954, 10.1021/ja025768t · DOI
Cited by
Items 101–127 of 127
Amino Acid and Peptide-Derived Co-Assembled Hydrogels for Cell Culture Applications
Liyanage, W., & Nilsson, B. L. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.158
Zhao, Y., Imura, T., Leman, L. J., Black, A. S., Bonnet, D. J., Maryanoff, B. E., Curtiss, L. K., & Ghadiri, M. R. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.026
An Improved Synthesis of Hemiasterlin
Yu, L., Jia, H., Xu, Q., Xu, J., Lee, S., & Tong, X. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.082
Analysis of Supramolecular Assemblies via Electrostatic Force Microscopy
Li, S., Sidorov, A., Mehta, A. K., Das, D., Jiang, Z., Orlando, T. M., & Lynn, D. G. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.156
Identification of the Novel Bioactive Peptides for Drosophila Orphan GPCRs
Ida, T., Tominaga, H., Iwamoto, E., Sato, T., Miyazato, M., & Kojima, M. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.086
Strategy for the Synthesis of Isotope-Labeled Branched Protein Mimics
Abel, S., Geltinger, B., Schwarzer, D., & Beyermann, M. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.214
García‐Ramos, Y., & Lubell, W. D. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.188
A Selective AIF/CypA Inhibitory Peptide Provides Protection in Neuronal Cells
Doti, N., Scognamiglio, P. L., Caporale, A., Reuther, C., Dolga, A. M., Plesnila, N., Culmsee, C., & Ruvo, M. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.182
Колик, Л. Г., Gudasheva, T. A., & Середенин, С. Б. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.196
Photoactive Prenylated Peptides for Studying Protein Isoprenylation
Vervacke, J. S., Funk, A. L., Schuld, N. J., Williams, C. L., Hrycnya, C., & Distefano, M. D. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.208
Self-citationChemical Synthesis of Human Relaxin-2
Chen, L., Dalhitski, A. V., Fleming, M. P., Hamilton, R. A., Liu, S., Moore, J. R., Nicholas, G. M., Nuiry, I. I., Vieth, A. J., & Withers, G. P. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.224
Analysis of N-Amino-Imidazolinone Turn Mimic Geometry
García‐Ramos, Y., Proulx, C., & Lubell, W. D. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.190
Design, Synthesis, and Conformational Analysis of Melanotropin Analogues of MTII and SHU9119
Grieco, P., Yousif, A. M., Carotenuto, A., Limatola, A., Brancaccio, D., Novellino, E., & Hruby, V. J. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.126
Cain, J. P., Chantell, C. A., Onaiyekan, M. A., & Menakuru, M. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.220
Sakamoto, K., Sato, K., Shigenaga, A., Tsuji, D., Itoh, K., & Otaka, A. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.242
Designed Peptide Libraries for Cell Analyzing Microarrays
Mihara, H., Usui, K., Tsutsumi, H., & Nokihara, K. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.022
Okada, A., Taniguchi, M., Usui, K., & Sugimoto, N. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.180
Platform Technology to Develop Synthetic Peptide Vaccines to Prevent Viral Infections
Jiang, Z., Gera, L., Hartsock, W. J., Yan, Z., Hirsch, B., Mant, C. T., Qian, Z., V., K. V. K., Kirwan, J. P., & Hodges, R. S. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.132
Diaz-Rodriguez, V. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)
Østergaard, S., Wong, S. K., Bang, S., Emsley, J., & Stennicke, H. R. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.098
Mode of Action of the Sulfhydryl Group in Virolytic Peptide Triazole Thiol Inhibitors of HIV-1
Bailey, L. D., Duffy, C., Li, H., Bastian, A. R., Emileh, A., & CHAIKEN, I. M. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.146
Small Molecules And Functionalized Peptides To Study Protein Prenylation
Vervacke, J. S. (2016) · University of Minnesota Digital Conservancy (University of Minnesota)
Poli, M. D., Zotti, M. D., Raftery, J., Aguilar, J. A., Morris, G. A., & Clayden, J. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.118
Functional Illumination in Living Cells
Ahadi, S., Bhardwaj, G., Pham, T., Sanchez, E., Olivos, D. J., Saunders, M. R., Tian, L., & Lam, K. S. (2013) · American Peptide Symposium (APS) · doi:10.17952/23aps.2013.166
Combinatorial Chemistry Online
Terrett, N. K. (2011) · Combinatorial Chemistry - an Online Journal · doi:10.1016/j.comche.2011.02.001
(2017) · Current Topics in Peptide & Protein Research
Self-citation
Metadata
- Authors
- Mullen, D. G., Kyro, K., Hauser, M., Gustavsson, M., Veglia, G., Becker, J. M., Naider, F., & Distefano, M. D.
- Affiliations
- University of Minnesota (US)
- University of Tennessee at Knoxville (US)
- College of Staten Island (US)
- Corresponding author
- Distefano, Mark D.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 19
- Issue
- 1
- Pages
- 490-497
- ISSN
- 0968-0896 (ISSN-L)
- PMC
- PMC3037452
- OpenAlex
- W2160244519
- Cited by
- 129
- References
- 56
- Citations by year
- 2025: 1 · 2023: 1 · 2020: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 3 · 2014: 1 · 2013: 110 · 2012: 5
- FWCI
- 16.07
- Type
- journal article
- Language
- en
- Update notices
- erratum (2011-05-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Bioorganic & Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health Grants (GM58442, GM22087)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Structural Characterization
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Synthetic Organic Chemistry
- Keywords
- A-factor, Saccharomyces cerevisiae, peptide synthesis, Fmoc solid-phase peptide synthesis, G protein-coupled receptors, mating pheromone
- MeSH terms
- Amino Acid Sequence, Amino Acids, Fluorenes, Fungal Proteins, Molecular Sequence Data, Magnetic Resonance Spectroscopy, Peptides, Photochemistry, Saccharomyces cerevisiae, Nuclear Magnetic Resonance, Biomolecular, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.